Encapsidation of a recombinant
We previously constructed a recombinant LulII parvovirus genome lacking viral coding sequences and used it to generate luciferase-transducing virions, by cotransfection of cells with a helper plasmid expressing LullI viral proteins. Here, we describe similar cotransfections using alternative, replication-defective helpers encoding the non-structural and capsid proteins of parvovirus HI, or of either the fibrotropic or lymphotropic parvovirus strain of minute virus of mice [MVM(p) or MVM(i)]. Each cotransfection generated transducing virus which directed luciferase expression after infection of HeLa cells. The transducing activity of virus produced using either LulII or HI helper plasmids could be specifically neutralized by antiserum raised against the corresponding infectious virus. When the recombinant LullI parvovirus was pseudotyped with MVM(p) or MVM(i), the resulting virions efficiently expressed luciferase after infection in human or murine cells known to be permissive for both MVM strains. The MVM(p) pseudotyped virus also expressed this reporter efficiently when infected into the murine A9 fibroblast line. In contrast, the recombinant virus generated with an MVM(i) helper gave luciferase expression that was barely detectable after infection of A9 cells which are highly restrictive for MVM(i) productive infection. These results support the notion that the allotropic determinant of these MVM strains functions through their capsid proteins. Pseudotyping of recombinant parvovirus genomes should be useful in controlling their host range as vectors, and in studying mechanisms influencing the permissiveness of parvovirus infections.
The autonomous parvovirus LuIII was originally isolated as a contaminant of a human cell culture (Hallauer et al., 1971) and its natural host is unknown. Sequence studies have shown that this virus is related to the rodent parvoviruses H1 and minute virus of mice (MVM) (e.g. showing approximately 80% amino acid similarity to these viruses within the C-terminal region of the capsid proteins, allowing conservative substitutions; our unpublished observations). Diffoot and Bates have constructed a clone of the LuIII genome, pGLu883, that can be propagated stably in recombination-deficient strains of Escherichia coli and that shows high infectivity on transfection into permissive mammalian cells (Rhode, 1989) . We have recently generated reporter genecontaining derivatives of pGLu883 which can be replicated and packaged into transducing virions when cotransfected into cells with a plasmid supplying LuIII viral helper functions in trans (Maxwell et al., 1993) . We now report that plasmids expressing the non-structural and capsid proteins of either parvovirus H1 or MVM can be used as alternative helpers for a recombinant LuIII genome.
The plasmid constructs used for transfection are shown in Fig. 1 . pGLuLUCASV was derived from pGLu883 by substitution of a firefly luciferase reporter gene for almost the entire viral coding sequences, as described elsewhere (Maxwell et al., 1993) . We previously demonstrated production of transducing virus by cells cotransfected with pGLuLUCASV and either of the replication-defective constructs, pGLuABE (Hanson & Rhode, 1991) or pSVLu ( Fig. 1) , used to supply LuIII parvovirus helper functions (non-structural and capsid proteins) in trans (Maxwell et al., 1993) . Luciferase activity was readily detected in HeLa cells after infection with the recombinant virus, pSR47B6, pMVMpA and pMVMi-6 (Fig. 1) (Cotmore & Tattersall, 1987) . NS and VPs, Coding regions for non-structural and capsid proteins, respectively. TAA, Termination codon for VPs. An, Polyadenylation signal. X, Xbal site used in constructing pGLuLUCASV (Maxwell et al., 1993) . SV, Simian virus 40 early promoter• Black bars represent parvoviral terminal inverted repeats; A indicates deletions involving these.
pGLuLUCASV was propagated in E. coli strain SURE (Stratagene). Other plasmids were grown in E. coli strain HB101. pSR47B6 was constructed as described previously for pSR1 (Rhode, 1985) . Plasmid clones pMVMpA and pMVMi-6 were derived from infectious clones of MVM(p) and MVM(i), respectively, supplied by P. Tattersall. They were derived by transformation into E. coli HB101 and repeated subculturing during a 1 week period, after which plasmids from single colonies were screened for right end deletions by SspI digestion. pMVMpA and pMVMi-6 have deletions of approximately 90 and approximately 170 nucleotides of right end sequence, respectively.
HeLa Gey cells were from ATCC. Two stocks of the NB324K line of simian virus 40-transformed human newborn kidney cells (Shein & Enders, 1962) were used; these are referred to as NB and 324K cells, respectively. The 324K cells, murine iD5 hybrid cells and murine A9 fibroblasts (Ball-Goodrich & Tattersall, 1992) were kindly supplied by P. Tattersall. PEJ/Rat2 cells are from the Rat2 cell line, transformed by an activated H-ras oncogene. Cells were maintained in Opti-MEM (Gibco) with 3.8 % fetal bovine serum. Antisera were obtained from hamsters which survived neonatal infection with either LuIII or H1 virus. A markedly higher titre was achieved for the anti-H1 than for the anti-LuIII serum (S. Rhode, unpublished) , as reflected in the neutralization results shown in Fig. 2 . Fig. 2 . Specific neutralization of transducing activity of LulII-helped or HI-helped GLuLUCASV virus by antisera raised against the cognate infectious virus. The viruses used were those from experiment 2, Table  1 . Dilutions of anti-H1 serum of < 10 ~ applied to the HI-helped virus virtually abolished its transducing activity (< 0.1% of control) but were without effect on the LuIII-helped virus. The converse result was obtained for the anti-LuIII serum, although the neutralizing titre of this serum against the cognate virus was much lower than for the anti-H1 serum. C), Hi/anti-H1 ; O, H1/anti-LuIII; A, LulII/anti-H1 ; ~x,
Cells were cotransfected by electroporation (Maxwell & Maxwell, 1988) using pGLuLUCASV DNA at 25 t~g/ml together with the indicated concentration of helper construct (covalently closed circular forms). The pulsed cells were cultured overnight in medium with 10% fetal bovine serum which was then replaced with maintenance medium. Medium containing released virions was collected 3 or 4 days following electroporation and either centrifuged at low speed or filtered (0'2 ~tm filter) before storage at -20 °C. Plaque assays of recombinant viral stocks on 324K cells were performed using a modification of the procedure of Tattersall & Bratton (1983) . For infection with transducing virus, recipient cells were seeded 1 day previously (2 x 105 cells per 6 cm dish) and were exposed to virus-containing culture supernatant or filtrate, diluted with maintenance medium in a total volume of 1 ml. After approximately 4 h at 37 °C, the dishes received an additional 1.5 ml medium and incubation was continued until extracts were prepared for luciferase assay, 20 to 29 h later. Values from replicate infections usually agreed closely (within 10% of the mean). To test for antibody neutralization of transducing activity, samples (1 ml) of diluted virus-containing medium were incubated for 30 rain at room temperature with antisera, diluted as indicated, before layering on recipient HeLa cells. Standard luciferase assays were performed as described (de Wet et aL, 1987; Maxwell & Maxwell, 1988) ; alternatively, the Promega Luciferase Assay System was used according to the manufacturer's instructions. This kit gave approximately sixfold more light units than did ]. The indicated helper plasmids were present at 40 gg/ml in the electroporatiou of the 324K producer cells (with 25~ag/ml pGLuLUCASV).
:~ ND, Not determined.
the standard assay [both using 10 s integration on a MonoLight 2001 luminometer (Analytical Luminescence)].
To determine whether the HI-derived construct could provide functions permitting replication and packaging of the LuIII-luciferase recombinant, cells were cotransfected by electroporation with pGLuLUCASV together with either pSR47B6 or pGLuABE, as a control LulII helper. Medium collected from the transfected cells after 3 to 4 days was overlaid on subconfluent HeLa cells (which are permissive for both LuIII and H1 infection) and extracts of these recipient cells were assayed the following day for luciferase activity. As shown in Table  1 , the two helper constructs functioned with comparable efficiency in supporting the production of transducing virus by transfected NB cells. Comparison of experiments 1 and 2 suggests that the optimal amount of transfected DNA may differ between the two helpers; we have not investigated this systematically. Experiment 3 (Table 1) shows that transducing virus was also produced by the PEJ/Rat2 cell line after similar cotransfection. However, in these rat cells, the LuIII helper supported virus production with considerably reduced efficiency relative to an equal amount of transfected H1 helper.
The above experiments indicated that transducing virus could be generated from the recombinant LuIII genome by using the non-structural and capsid proteins of H 1. This conclusion was confirmed by demonstrating, as shown in Fig. 2 , that the transducing activity of the resulting virus was neutralized by antiserum to H1 capsid, but was unaffected by antiserum to LuIII. The converse result was obtained for transducing virus produced using the pGLuABE LuIII helper (Fig. 2) . Therefore, in each case, transduction of the luciferase gene was dependent on the capsid encoded in the helper construct.
To determine whether MVM could also supply helper functions to the recombinant LuIII, 324K cells were cotransfected with pGLuLUCASV and pMVMpA or pMVMi-6 (Fig. 1) . pSVLu was cotransfected in parallel as a control. As shown in Table 2 (experiment 1), use of either MVM helper supported the production of virus capable of transducing HeLa cells, although the transduced luciferase activity was lower than when pSVLu was used as helper. (Luciferase values cannot be compared directly between Tables 1 and 2 for reasons including the use of different cells for transfection and a more sensitive assay in the Table 2 experiments.) HeLa cells have previously been shown to be capable of infection by MVM, although not capable of supporting a fully productive infection (Fox et al., 1990) . As shown in experiment 2, Table 2, 324K cells, which are permissive for both MVM(p) and MVM(i), expressed approximately threefold higher luciferase activity than HeLa cells when infected with the MVM-helped virus preparations.
The availability of a recombinant LuIII genome packaged in the capsid from either MVM strain allowed us to investigate whether the capsid of such pseudotyped viruses would be sufficient to impose the cell tropism of its parental virus. For this, we used the murine A9 fibroblast line which is permissive for MVM(p) but restrictive for MVM(i) (Tattersall & Bratton, 1983) . For comparison, we also infected the murine iD5 cell line which is permissive for both MVM strains, being a hybrid derived by fusion of A9 with MVM(i)-permissive EL4 T cells (Ball-Goodrich & Tattersall, 1992) . As shown in Table 2 (experiments 3 and 4), the recombinant virus generated using the MVMpA helper expressed luciferase efficiently in A9 cells. In contrast, expression in A9 from the MVMi-6 helped virus was > 1400-fold decreased, being barely detectable. Both viruses expressed luciferase efficiently when infected into iD5 cells. Thus, the ability of the recombinant viruses to express the transduced luciferase gene in A9 cells reflected the permissiveness or restrictiveness of these cells for the parental MVM strains that had supplied the helper functions.
Despite the deletion of most of the fight palindrome, previous results (S. Rhode, unpublished) have indicated that cells transfected with pSR47B6 ( Fig. 1) were capable of producing low levels of a replication-competent, HIrelated virus. If this were also the case for pMVMpA, it is possible that expression of luciferase in A9 cells, transduced by GLuLUCASV generated with this helper, could be dependent on co-infection with replicationcompetent MVM(p). The following results appear to exclude this possibility. Plaque assays, performed on two preparations of pMVMpA-helped GLuLUCASV, showed that a low level of replication-competent virus was indeed present. However, in each case, the titre was 2 x 103 p.f.u./ml, which would have been sufficient to infect only 0.1 to 0.2% of the recipient cells in our transduction experiments. Since transduced luciferase activity was assayed approximately 24 h post-infection, the frequency of cells co-infected with GLuLUCASV and replication-competent virus must have been extremely low. Furthermore, as shown in Fig. 3 , we observed a linear relationship between transduced luciferase activity in A9 cells and the input volume of GLuLUCASVcontaining culture supernatant used to infect these cells. Had co-infection been required for the reporter expression, the latter would have been expected to increase with the square of the input volume. Therefore, we conclude that transduction and expression of the recombinant genome, encapsidated by an MVM(p) helper, in recipient A9 cells was not dependent on the presence of a wild-type MVM genome.
The production of recombinant, autonomous parvoviruses (Russell et aI., 1992; Maxwell et al., 1993) opens the possibility of their use as vectors in various gene transfer applications. The spectrum of cell types supporting LuIII infection is not well defined and we have found considerable variation among cell lines in the efficiency of transduction by recombinant LuIII. Pseudotyping the recombinant using capsid proteins from other parvoviruses would potentially expand the range of target cells for gene transfer. The experiments reported here demonstrate the feasibility of such pseudotyping with capsids of either H1 or MVM. The nonstructural proteins of these heterologous viruses evidently functioned efficiently to allow excision and replication of the recombinant LuIII DNA from the plasmid in which it was transfected.
Pseudotyped recombinant parvoviruses should be of use in elucidating intracellular interactions that influence whether an infection will be abortive or productive. Permissiveness for productive infection by MVM(p) compared to MVM(i) is determined at an intracellular level by putative interaction between differentiationrelated cellular proteins and determinants in the virion (Spalholz & Tattersall, 1983; Gardiner & Tattersall, 1988a) . The coding information for these determinants has been mapped to the capsid coding region, where two amino acid differences are crucial (Ball-Goodrich & Tattersall, 1992) in specifying the fibroblast tropism of MVM(p) versus the T lymphoid tropism of MVM(i). Efficient initiation of a single-cycle infection by transfection with cloned infectious DNA of either MVM strain is not subject to the cell type restriction seen with infection (Gardiner & Tattersall, 1988 a) , suggesting that this restriction is mediated by capsid proteins. However, in previous work (Antonietti et al., 1988; Gardiner & Tattersall, 1988b; Ball-Goodrich & Tattersall, 1992) , the possibility of additional direct involvement of the type-specific DNA sequence was not excluded, because this DNA was always introduced together with the homologous capsid in the intertypic recombinant or site-directed mutant viruses studied. The packaging of a heterologous reporter genome, lacking viral coding sequences, avoids this association. Our results showing expression of transduced luciferase on infection of A9 fibroblasts with MVM(p)-packaged, but not MVM(i)-packaged, recombinant LuIII parvovirus support the notion that the respective capsid proteins are sufficient to determine permissiveness in these cells (at least up to the stage of establishing transcription from the P4 promoter used to drive the luciferase reporter). Pseudotyped recombinants similar to those we have described should be useful in elucidating other examples of restrictive versus permissive infection among parvoviruses.
Note added in proof The entire LuIII nucleotide sequence together with details of the construction of pGlu883 has now been published [Diffoot et aL (1993) . Virology t92, 339-345].
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